Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple myeloma treatment, potentially sparing patients from more invasive and costly bone marrow aspirations. | Quest ...
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the launch of a novel ...
Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...
News Medical on MSN
New platform improves prediction of human antibody drug responses
An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how antibody medicines are tested and brought to patients. The work, published ...
Llama antibodies clamp the coronavirus shut at its weakest spot—leaving the virus powerless to mutate or infect.
A team of researchers at the Indian Institute of Technology (IIT) Roorkee on Tuesday announced the development of a next-generation antibody discovery platform that has the potential to transform ...
Antibodies are the immune system's precision tools for recognizing and neutralizing viruses, bacteria and other foreign ...
An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how antibody medicines are tested and brought to patients. The work, published ...
Telehealth company Hims & Hers has added Grail’s blood cancer test Galleri to its offerings as the medtech has now sent off ...
Medical Device Network on MSN
Quest launches flow cytometry MRD test for myeloma
Quest expects the new blood test will support response monitoring in clinical trials.
SAN JOSE, Calif., January 08, 2026--(BUSINESS WIRE)--Today, Visby Medical announced two new relationships that will expand national access to the Visby Women’s Sexual Health Test, the first, at-home, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results